Answers are grounded in this paper and cite their sources.
Psoriasis is a chronic, immune-mediated inflammatory skin disease characterized by disrupted keratinocyte proliferation and differentiation, activation of innate and adaptive immunity, and the establishment of a persistent inflammatory process. Current research highlights the pivotal role of the interleukin-23 (IL-23)/interleukin-17 (IL-17) immune axis in the disease's pathogenesis. Investigating the molecular and cellular mechanisms of psoriasis is crucial for understanding its chronic, relapsing course and for developing targeted therapies.
No takes yet. Share an insight, caveat, or question.
G. et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: